PROF (Profound Medical) Shiller PE Ratio: (As of Jul. 19, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PROF Profound Medical Corp PROF
69 GF Score
Price $6.81
GF Value $14.51
Valuation Possible Value Trap
! 1 Warning Sign
View Full Analysis

What is Profound Medical Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Profound Medical  (NAS:PROF) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Profound Medical Shiller PE Ratio Related Terms


Profound Medical Shiller PE Ratio Historical Data

* Premium members only.

The historical data trend for Profound Medical's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Profound Medical Shiller PE Ratio Chart

Profound Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Profound Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

PROF vs ABT, SYK, MDT: Shiller PE Ratio Comparison

For the Medical Devices subindustry, Profound Medical's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Profound Medical Shiller PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Profound Medical's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Profound Medical's Shiller PE Ratio falls into.


PROF
69GF Score
Profound Medical Corp PROF
Shiller PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Profound Medical Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Profound Medical's E10 for the quarter that ended in Mar. 2026 is calculated as:

For example, Profound Medical's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.19/132.2623*132.2623
=-0.190

Current CPI (Mar. 2026) = 132.2623.

Profound Medical Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201606 -0.696 102.002 -0.902
201609 -0.761 101.765 -0.989
201612 -0.696 101.449 -0.907
201703 -0.525 102.634 -0.677
201706 -0.615 103.029 -0.790
201709 -0.725 103.345 -0.928
201712 -0.450 103.345 -0.576
201803 -0.465 105.004 -0.586
201806 -0.380 105.557 -0.476
201809 -0.372 105.636 -0.466
201812 -0.258 105.399 -0.324
201903 -0.202 106.979 -0.250
201906 -0.411 107.690 -0.505
201909 -0.431 107.611 -0.530
201912 -0.320 107.769 -0.393
202003 -0.210 107.927 -0.257
202006 -0.330 108.401 -0.403
202009 -0.330 108.164 -0.404
202012 -0.400 108.559 -0.487
202103 -0.370 110.298 -0.444
202106 -0.350 111.720 -0.414
202109 -0.290 112.905 -0.340
202112 -0.490 113.774 -0.570
202203 -0.400 117.646 -0.450
202206 -0.280 120.806 -0.307
202209 -0.240 120.648 -0.263
202212 -0.460 120.964 -0.503
202303 -0.330 122.702 -0.356
202306 -0.330 124.203 -0.351
202309 -0.260 125.230 -0.275
202312 -0.420 125.072 -0.444
202403 -0.270 126.258 -0.283
202406 -0.280 127.522 -0.290
202409 -0.380 127.285 -0.395
202412 -0.200 127.364 -0.208
202503 -0.360 129.181 -0.369
202506 -0.520 129.892 -0.529
202509 -0.260 130.287 -0.264
202512 -0.270 130.366 -0.274
202603 -0.190 132.262 -0.190

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Profound Medical (PROF) Overvalued in 2026?

Based on GuruFocus' analysis, Profound Medical stock appears to be undervalued. The current stock price of $6.81 is trading 53.1% below its estimated GF Value™ of $14.51. GuruFocus considers Profound Medical to be Possible Value Trap.

Key valuation signals for PROF:

  • Shiller PE Ratio:
  • GF Value™: $14.51 vs. price of $6.81 (53.1% below fair value)
  • GF Score™: 69/100 with 1 warning sign

No single metric tells the full story. See the PROF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Profound Medical Business Description

Other Exchanges PRN:Canada
Address 2400 Skymark Avenue, Unit 6, Mississauga, ON, CAN, L4W 5K5
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.
69GF Score

Get the complete analysis for PROF

Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.81
Price
$14.51
GF Value